NCT00002173View on ClinicalTrials.gov

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

BIOLOGICAL

HIV-1 Immunogen

Trial Locations (1)

92008

Immune Response Corp, Carlsbad

All Listed Sponsors

lead

The Immune Response Corporation

INDUSTRY